Description
For use as an adjunct to intramammary therapy in the treatment of acute bacterial mastitis with systemic involvement, caused by organisms sensitive to framycetin in dairy cows. In vitro, framycetin has shown activity against Escherichia coli, Staphylococcus aureus, Arcanobacterium pyogenes and Klebsiella spp.
